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A BST R AC T   
 
Aim: To investigate the prevalence of uveitis in ankylosing spondylitis (AS) patients and its 
relationship with HLA B27. 
Methods: The data of 95 patients with AS who admitted to Tokat Gaziosmanpaşa University Internal 
Medicine and Rehabilitation Outpatient Clinics between 2010 and 2019 were analyzed 
retrospectively. Demographic characteristics, HLA B27 positivity and detailed eye consultation notes 
of the patients were recorded. 
Results: Of the 95 patients, 65 (68%) were male and 30 (32%) were female. The mean age of the 
patients was 38.3 ± 11.6 years. The HLA B27 results of 10 patients could not be reached. 22% of the 
patients had at least one episode of uveitis attack. While 82% (70/85) of patients had HLA B27 
positivity, this rate was 86% in (18/21) patients with uveitis.  
Conclusion: Uveitis is a disease that can cause permanent loss of vision. In our study, no significant 
difference was found between the presence of uveitis and the presence of HLA B27 in patients with 
AS and this finding needs to be supported by randomized studies. 
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Introduction 
Ankylosing spondylitis (AS) is a chronic 
progressive disease that causes destruction and 
fusion of the spinal vertebrae and sacroiliac 
joints. Extra-articular organs such as eyes, skin 
and cardiovascular system may be affected in 
the disease [1]. The most common extra-
articular involvement is uveitis and it occurs in 
30-57% of patients [2,3]. Genetic 
predisposition is strong in the disease and 
human leukocyte antigen-B27 (HLA-B27) is 
very important parameter in the diagnosis. 
Inflammation of the uveal tissues of the eye is 
called as uveitis.  While it can affect different 
localizations such as anterior, intermedier and 
posterior segment of the eye separately, it can 
be also seen together with all localizations as 
EXPERIMENTAL BIOMEDICAL RESEARCH 
http://www.experimentalbiomedicalresearch.com 
                                                        Demir et al.  Exp Biomed Res 2019; 2(4):132-135 




panuveitis. The localization of uveitis, 
presence of hypopyon, and characterization of 
keratic precipitates in the cornea endothelium 
give us very important information about the 
etiology of the disease. Patients with AS are 
usually expected to have anterior uveitis. In the 
disease, keratic precipitates are thin, non-
pigmented and distributed over the entire 
cornea. 
The aim of this study was to evaluate the 
findings of eye examination in AS patients and 




The data of 95 AS patients who admitted to 
Internal Medicine or Physical Therapy and 
Rehabilitation outpatient clinics of Tokat 
Gaziosmanpaşa University between 2010 and 
2019 were analyzed retrospectively. Ethics 
committee approval was obtained from 
Gaziosmanpaşa University Clinical Research 
Ethics Committee (Decision no: 19-KAEK-
088) and the study was carry out in accordance 
with Helsinki declaration. The patients’ data of 
demographic characteristics, HLA-B27 
results, and eye consultation notes were 
recorded retrospectively. The diagnosis of AS 
was made according to the modified New York 
criteria [4]. Patients who were not followed up 
in our hospital were excluded from the study. 
The best visual acuity, slit-lamp 
biomicroscopic and dilated fundus 
examination of the patients were performed in 
ophthalmologic clinic. The findings of uveitis 
including thyndal, hypopyon, synechia, 
vitreous cells and macular edema were 
recorded. 
After the data were coded, SPSS version 18.0 
was used for statistical analysis. Values were 
expressed as mean ± standard deviation, 
percentage ratios were also specified. Chi-
square test was used for the analysis of the 
qualitative data. For statistical comparison p> 
0.05 level was accepted as significant. 
 
Results  
There were 95 patients in the study, of them 65 
(68%) were male and 30 (32%) were female. 
The mean age of the patients was 38.3 ± 11.6 
years. Eighty five patients have HLA-B27 
results, 70 patients of them (%82) were 
positive. 21 patients (22%) had at least one 
episode of uveitis attack. The rate of HLA B27 
positivity was 86% in (18/21) patients with 
uveitis (p = 0.104).  
When the patients with uveitis were examined 
in detail, all patients had signs of anterior 
uveitis. Dilated fundus examination revealed 
there was no vitreous cell. Macular edema was 
observed in two patients. Intraocular pressure 
was increased in two patients and it was 
controlled with topical medical treatment. 
Cataract was not detected in any of the case. 
 
Discussion 
AS is the most common disease among 
spondyloarthropathies and its association with 
uveitis is well known [5]. Human leukocyte 
antigen-27 (HLA-B27) positivity is very high 
in AS cases and this genetic finding is also 
detected in idiopathic anterior uveitis. It is not 
clear why there is HLA-B27 positivity in 
patients with uveitis, but possible theories to 
explain this condition have been proposed. 
One of the most widely accepted theories is 
that HLA-B27 antigens and some gram-
negative bacteria have common amino acid 
sequences and auto-antibodies against these 
bacteria are targeted to the body's own tissues. 
The findings of recent studies demonstrating 
the antibodies against the C. trachomatis, 
Klebsiella and Saccharomyces cerevisiae in 
uveitis patients support this theory [6].  
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Uveitis is a disease characterized by specific 
clinically findings including painful redness, 
sensitivity to sunlight, lacrimation, decreased 
vision, meiosis and blepharospasm [7]. The 
findings of uveitis in the eye provide important 
information about the etiology of the disease. 
Scattered non-pigmented keratic precipitates 
on endothelial cells, ciliary hyperemia, and 
anterior uveitis is the most common findings of 
uveitis in patients with AS [8]. Granulomatous 
anterior uveitis is not an expected finding in 
these patients. Unilateral and acute onset 
uveitis is expected in the fourth decade of the 
patients [9]. All of our patients had anterior 
uveitis. In accordance with the literature, none 
of our patients had granulomatous keratic 
precipitates. In a recent study conducted in our 
country, it is showed that the incidence of eye-
related complications in AS patients was 57%, 
and there was no statistical difference between 
early and late onset and ocular involvement 
[2].  
Well known etiologic factors of uveitis are past 
systemic infection and antibiotic use, but 
idiopathic causes are the leading cause of 
anterior uveitis. Furthermore, AS is another 
important etiologic risk factors [10]. Clinical 
findings in these patients may affect the 
occurrence of uveitis. Sun et al. showed in their 
study that presence of hip joint lesion or 
peripheral joint involvement is associated with 
was more frequent uveitis [11]. It is also 
demonstrated that serum anti-streptolysin O 
(ASO) and circulating immune complexes 
were detected significantly higher in uveitis 
cases in the study. The finding of ASO 
elevation associated with a recent infection 
suggests that the targeting of the immune 
response secondary to infection may have a 
role in the etiology of uveitis [12]. Despite all 
these findings, HLA B27 positivity was found 
to be associated with uveitis regardless of other 
findings in AS patients [13]. In addition, 
approximately 20% of HLA B27 negative AS 
cases show at least 1 uveitis attack. The clinical 
manifestations of AS in patients with AS was 
investigated in a recent study of Arévalo et al. 
and it was found that the presence of HLA B27 
in these patients was associated with early 
onset of the disease and familial clustering, 
while the absence of HLA B27 was associated 
with higher peripheral arthritis, typectitis and 
extra articular findings [14]. Contrary to 
expectations, HLA B27 positivity was not 
associated with the presence of uveitis in their 
study. In parallel with this study, HLA B27 
positivity was detected in 86% of AS patients 
with uveitis and this rate was 82% in all AS 
patients, and there was no significant 
difference in our study. 
Uveitis, which can be treated effectively by 
timely intervention, can cause serious 
complications such as permanent blindness 
[15]. Uveitis may be accompanied by 
subclinical symptoms instead of classical 
symptoms. This may cause delay in diagnosis. 
The incidence of uveitis was 22% in our study. 
HLA B27 positivity was not found to be 
related to occurrence of uveitis in the patients. 
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